HoldsUp

Iain Campbell

University of Edinburgh

Iain Campbell is a neuroscientist at the University of Edinburgh specializing in metabolic psychiatry. His research investigates the metabolic mechanisms and interventions associated with severe mental illness, particularly bipolar disorder and schizophrenia. His published work focuses on therapeutic ketosis, ketogenic metabolic therapies, insulin signaling, mitochondrial dysfunction, and diet-drug interactions in psychiatric care.

29 claims checked on air: 4 context 1 contradicted 1 overstated 17 supported 6 unverified

What they said on air - contradicted

4 citing their own research

1:08:13contradictedmoderateIs Bipolar Disorder Really a Diet Problem?

Lamotrigine treatment typically produces reductions in brain glutamate levels over a period of approximately three months.

"And the reductions you typically see in, like, three months, for example, on lamotrigine, but we were seeing much larger reductions in six to eight weeks of a ketogenic diet." (said at 1:08:13)

Human magnetic resonance spectroscopy (MRS) studies examining the effect of lamotrigine on brain glutamate levels over 8 to 12 weeks (approximately 2 to 3 months) do not show consistent or typical reductions in overall brain glutamate. In an MRS study of depressed bipolar patients treated with lamotrigine for 10–12 weeks, lamotrigine had no significant overall effect on glutamate/glutamine (Glx) levels in the anterior cingulate cortex, and clinical responders actually exhibited an increase in Glx. Similarly, an 8-week trial in older patients with bipolar depression found no significant changes in glutamate-to-creatine ratios following lamotrigine therapy. While preclinical animal models suggest lamotrigine inhibits presynaptic glutamate release, human in vivo imaging over this timeframe does not demonstrate typical reductions in tissue glutamate concentrations.

Fact-checked episodes

Publications